Literature DB >> 11060493

Actions of melatonin in the reduction of oxidative stress. A review.

R J Reiter1, D X Tan, C Osuna, E Gitto.   

Abstract

Melatonin was discovered to be a direct free radical scavenger less than 10 years ago. Besides its ability to directly neutralize a number of free radicals and reactive oxygen and nitrogen species, it stimulates several antioxidative enzymes which increase its efficiency as an antioxidant. In terms of direct free radical scavenging, melatonin interacts with the highly toxic hydroxyl radical with a rate constant equivalent to that of other highly efficient hydroxyl radical scavengers. Additionally, melatonin reportedly neutralizes hydrogen peroxide, singlet oxygen, peroxynitrite anion, nitric oxide and hypochlorous acid. The following antioxidative enzymes are also stimulated by melatonin: superoxide dismutase, glutathione peroxidase and glutathione reductase. Melatonin has been widely used as a protective agent against a wide variety of processes and agents that damage tissues via free radical mechanisms. Copyright 2000 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060493     DOI: 10.1007/bf02253360

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  193 in total

1.  Effect of stress and dexamethasone treatment on circadian rhythms of melatonin and corticosterone in ring dove (Streptopelia risoria).

Authors:  Carmen Barriga; Jose María Marchena; Robert William Lea; Steve Harvey; Ana Beatriz Rodríguez
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

2.  Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury.

Authors:  Hong-Hwa Chen; Chia-Lo Chang; Kun-Chen Lin; Pei-Hsun Sung; Han-Tan Chai; Yen-Yi Zhen; Yi-Ching Chen; Ying-Chung Wu; Steve Leu; Tzu-Hsien Tsai; Chih-Hung Chen; Hsueh-Wen Chang; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

3.  Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study.

Authors:  H Aly; H Elmahdy; M El-Dib; M Rowisha; M Awny; T El-Gohary; M Elbatch; M Hamisa; A-R El-Mashad
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

4.  Urinary metabolites and antioxidant products of exogenous melatonin in the mouse.

Authors:  Xiaochao Ma; Jeffrey R Idle; Kristopher W Krausz; Dun-Xian Tan; Leopoldo Ceraulo; Frank J Gonzalez
Journal:  J Pineal Res       Date:  2006-05       Impact factor: 13.007

5.  Protective effect of melatonin and omeprazole against alendronat-induced gastric damage.

Authors:  Goksel Sener; Figen Onuk Goren; Nefise B Ulusoy; Yasemin Ersoy; Serap Arbak; Gül Ayanoglu Dülger
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 6.  Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas.

Authors:  Russel J Reiter; Sergio Rosales-Corral; Dun Xian Tan; Mei Jie Jou; Annia Galano; Bing Xu
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

7.  Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor.

Authors:  Jesus Pintor; Teresa Peláez; Charles H V Hoyle; Assumpta Peral
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Melatonin and tumeric ameliorate aging-induced changes: implication of immunoglobulins, cytokines, DJ-1/NRF2 and apoptosis regulation.

Authors:  Ismail Ahmed Ismail; Hanan A El-Bakry; Safaa S Soliman
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-04-20

Review 9.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

Review 10.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.